Literature DB >> 18330889

P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.

Mahboobeh Mahdavinia1, Faraz Bishehsari, Fabio Verginelli, Albana Cumashi, Rossano Lattanzio, Masoud Sotoudeh, Reza Ansari, Daniela Semeraro, Mahshid Hormazdi, Hafez Fakheri, Naser Rakhshani, Laura De Lellis, Maria Cristina Curia, Alessandro Cama, Mauro Piantelli, Reza Malekzadeh, Stefano Iacobelli, Renato Mariani-Costantini.   

Abstract

CRC-associated P53 mutations have not been studied extensively in non-Western countries at relatively low CRC risk. We examined, for the first time, 196 paraffin-embedded CRC cases from Northern Iran for mutations in P53 exons 5-8 using PCR-direct sequencing. P53 status and mutation site/type were correlated with nuclear protein accumulation, clinicopathologic variables and data on K-ras mutations and high-level microsatellite instability (MSI-H). We detected 96 P53 mutations in 87 (44.4%) cases and protein accumulation in 84 cases (42.8%). P53 mutations correlated directly with stage and inversely with MSI-H. Distal CRCs were more frequently mutated at major CpG hotspot codons [248 (8/66, 12.1%), 175 (7/66, 10.6%), and 245 (7/66, 10.6%)], while in proximal tumors codon 213, emerged as most frequently mutated (5/28, 17.9% vs. 3/66, 4.5%, P = 0.048). Transitions at CpGs, the most common mutation type, were more frequent in non-mucinous (25% vs. 10.4% in mucinous, P = 0.032), and distal CRC (27% vs. 12.5% in proximal, P = 0.02), and correlated with K-ras transversions. Transitions at non-CpGs, second most common P53 mutation, were more frequent in proximal tumors (15.6% vs. 4.7% in distal, P = 0.01), and correlated with K-ras transitions and MSI-H. Overall frequency and types of mutations and correlations with P53 accumulation, stage and MSI-H were as reported for non-Iranian patients. However P53 mutation site/type and correlations between P53 and K-ras mutation types differed between proximal and distal CRC. The codon 213 P53 mutation that recurred in proximal CRC was previously reported as frequent in esophageal cancer from Northern Iran. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18330889     DOI: 10.1002/jcp.21428

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients.

Authors:  Muhammad U Rashid; Sidra Gull; Kashif Asghar; Noor Muhammad; Asim Amin; Ute Hamann
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

2.  Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis.

Authors:  Jing Zhang; Wen-Lei Zhuo; Ying Zheng; Yun-Song Zhang
Journal:  Med Oncol       Date:  2009-06-05       Impact factor: 3.064

3.  Microsatellite instability and protein expression of MLH1 and MSH2 genes in young Mexican patients less than 50 years of age diagnosed with colorectal cancer.

Authors:  Arturo Quintanilla-Guzman; Arturo Luevano-Gonzalez; Ada Nayeli Rangel-Gomez; Augusto Rojas-Martinez; Raquel Garza-Guajardo; Oralia Barboza-Quintana; Jesus Ancer-Rodriguez; Clara Patricia Rios-Ibarra; Rocio Ortiz-Lopez
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer.

Authors:  Diana L Esposito; Federica Aru; Rossano Lattanzio; Annalisa Morgano; Michela Abbondanza; Reza Malekzadeh; Faraz Bishehsari; Rosa Valanzano; Antonio Russo; Mauro Piantelli; Antonio Moschetta; Lavinia Vittoria Lotti; Renato Mariani-Costantini
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

5.  Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids.

Authors:  Serena Veschi; Rossano Lattanzio; Gitana Maria Aceto; Maria Cristina Curia; Salvatore Magnasco; Domenico Angelucci; Alessandro Cama; Mauro Piantelli; Pasquale Battista
Journal:  Int J Oncol       Date:  2012-07-20       Impact factor: 5.650

Review 6.  Colorectal cancer in iran: molecular epidemiology and screening strategies.

Authors:  Roya Dolatkhah; Mohammad Hossein Somi; Mortaza Jabbarpour Bonyadi; Iraj Asvadi Kermani; Faris Farassati; Saeed Dastgiri
Journal:  J Cancer Epidemiol       Date:  2015-01-15

7.  Transitions at CpG dinucleotides, geographic clustering of TP53 mutations and food availability patterns in colorectal cancer.

Authors:  Fabio Verginelli; Faraz Bishehsari; Francesco Napolitano; Mahboobeh Mahdavinia; Alessandro Cama; Reza Malekzadeh; Gennaro Miele; Giancarlo Raiconi; Roberto Tagliaferri; Renato Mariani-Costantini
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

8.  Mutation Analysis of TP53 Tumor Suppressor Gene in Colorectal Cancer in Patients from Iran (Kerman Province).

Authors:  Azadeh Lohrasbi Nejad; Mohammad Mehdi Yaghoobi
Journal:  Iran J Basic Med Sci       Date:  2012-01       Impact factor: 2.699

9.  Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran.

Authors:  Rahim Golmohammadi; Mohammad J Namazi; Mehdi Nikbakht; Mohammad Salehi; Mohammad H Derakhshan
Journal:  Gut Liver       Date:  2013-04-09       Impact factor: 4.519

10.  Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls.

Authors:  Wenlei Zhuo; Yunsong Zhang; Zhaolan Xiang; Lei Cai; Zhengtang Chen
Journal:  J Exp Clin Cancer Res       Date:  2009-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.